Synthesis and biological evaluation of novel 2,3-dihydrochromeno[3,4-d]imidazol-4(1H)-one derivatives as potent anticancer cell proliferation and migration agents.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European journal of medicinal chemistry

• Publication date

  2016-05-23

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejmech.2016.01.035PMID 26994691
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics, 2012

  2015cited by this paper
• Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents.

  2014cited by this paper
• Recent progress in the identification of BRAF inhibitors as anti-cancer agents.

  2014cited by this paper
• Synthesis of new 4-thiazolidinone-, pyrazoline-, and isatin-based conjugates with promising antitumor activity.

  2012cited by this paper
• Coumarin polysulfides inhibit cell growth and induce apoptosis in HCT116 colon cancer cells.

  2012cited by this paper
• Trends in cancer mortality in China: an update.

  2012cited by this paper
• Coumarin-based benzopyranone derivatives induced apoptosis in human lung (A549) cancer cells.

  2012cited by this paper
• Synthesis, biological activity and docking study of imidazol-5-one as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.

  2012cited by this paper
• Novel Phosphoinositide 3-Kinase/mTOR Dual Inhibitor, NVP-BGT226, Displays Potent Growth-Inhibitory Activity against Human Head and Neck Cancer Cells In Vitro and In Vivo

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

  2011cited by this paper
• Phase II Trial of Rituximab in the Treatment of Inhibitors in Congenital Hemophilia A: Results of the RICH Study

  2011cited by this paper
• Synthesis and molecular docking study of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential antitumor agents.

  2010cited by this paper
• GSK690693 Delays Tumor Onset and Progression in Genetically Defined Mouse Models Expressing Activated Akt

  2010cited by this paper
• A synthetic coumarin (4-methyl-7 hydroxy coumarin) has anti-cancer potentials against DMBA-induced skin cancer in mice.

  2009cited by this paper
• Hybrid molecules with a dual mode of action: dream or reality?

  2008cited by this paper
• Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity

  2008cited by this paper
• A review of coumarin derivatives in pharmacotherapy of breast cancer.

  2008cited by this paper
• Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers.

  2008cited by this paper
• Kurzzeit-Therapie des Ulcus duodeni mit Omeprazol und Ranitidin: Ergebnisse einer deutschen Multizenterstudie

  2008cited by this paper
• The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations.

  2007cited by this paper
• The Structure of a Human p110α/p85α Complex Elucidates the Effects of Oncogenic PI3Kα Mutations

  2007cited by this paper
• Synthesis and anti-hepatitis B virus activity of novel benzimidazole derivatives.

  2006cited by this paper
• Synthesis and anti-angiogenesis activity of coumarin derivatives.

  2006cited by this paper
• Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer.

  2004cited by this paper
• Studies on cancer chemoprevention by traditional folk medicines XXIV. Inhibitory effect of a coumarin derivative, 7-isopentenyloxycoumarin, against tumor-promotion.

  2002cited by this paper
• A new series of imidazolones: highly specific and potent nonpeptide AT1 angiotensin II receptor antagonists.

  1993cited by this paper
• [Short-term therapy of duodenal ulcer with omeprazole and ranitidine. Results of a German multicenter study].

  1985cited by this paper

• Recent advances in the design and synthesis of coumarins and their derivatives via Suzuki–Miyaura reaction (2002–2024)

  2025cites this paper
• Current landscape and recent developments of PI3K/AKT/mTOR targeted inhibitors for breast carcinoma.

  2025cites this paper
• Acetylcholine Inhibitory Study of Novel Thio Linked Coumarin-Benzimidazole Derivatives: Design, Synthesis, Computational, and In Silico Molecular Docking Studies

  2024cites this paper
• Coumarins and Hesperetin Inhibit Human Respiratory Syncytial Virus Infection

  2024cites this paper
• Synthesis and Anticancer Activities of Amide-Bridged Coumarin–Quinazolinone Hybrid Compounds

  2024cites this paper
• Synthesis, Molecular Electron Density Theory Study, Molecular Docking, and Pharmacological Evaluation of New Coumarin–Sulfonamide–Nitroindazolyl–Triazole Hybrids as Monoamine Oxidase Inhibitors

  2024cites this paper
• Coumarin as an Elite Scaffold in Anti-Breast Cancer Drug Development: Design Strategies, Mechanistic Insights, and Structure–Activity Relationships

  2024cites this paper
• Therapeutic Effects of Coumarins with Different Substitution Patterns

  2023cites this paper
• Coumarin-Piperazine Tethered 1,2,3-Triazoles: EGFR Targeting Anti-Breast Cancer Evaluation and Molecular Docking Studies

  2023cites this paper
• Pd‐Catalyzed Intramolecular Hydroaminocarbonylation of 3‐Allyl‐4‐arylaminocoumarins: Synthesis of Six‐ and Seven‐membered Ring Lactams Fused to the Coumarin Scaffold

  2023cites this paper
• A short review on the synthesis of oxazolo/thiazolo/imidazolocoumarins and their biological activities

  2023cites this paper
• A Brief Review on the Design, Synthesis and Biological Evaluation of Pyrazolo[c]coumarin Derivatives

  2023cites this paper
• Synthesis of imidazolocoumarins by the amide-directed oxidative cyclisation of enol-Ugi derivatives.

  2022cites this paper
• Recent advances on anticancer activity of coumarin derivatives

  2022cites this paper
• Synthesis and Biological Properties of Coumarin Derivatives. A Review

  2021cites this paper
• Discovery of novel 2H-chromene-3-carbonyl derivatives as selective estrogen receptor degraders (SERDs): Design, synthesis and biological evaluation.

  2021cites this paper
• Chemoselective bioconjugation based on modular click chemistry with 4-halocoumarins and aryl sulfonates

  2021cites this paper
• A review: Biologically active 3,4-heterocycle-fused coumarins.

  2020cites this paper
• Synthesis, characterization, molecular docking and DNA cleavage study of transition metal complexes of o-vanillin and glycine derived Schiff base ligand

  2020cites this paper
• Overview on developed synthesis procedures of coumarin heterocycles

  2020cites this paper
• Rational approaches of drug design for the development of selective estrogen receptor modulators (SERMs), implicated in breast cancer.

  2019cites this paper
• Synthesis, antibacterial, anticancer and molecular docking studies of macrocyclic metal complexes of dihydrazide and diketone

  2019cites this paper
• Pharmacological Evaluation on Antihypertensive Activity of a Novel AT1 Angiotensin II Receptor Antagonist

  2019cites this paper
• Brønsted Acid-promoted Facile Synthesis of N-Fused Angular Imidazoquinolines

  2018cites this paper
• Novel SERMs based on 3-aryl-4-aryloxy-2H-chromen-2-one skeleton - A possible way to dual ERα/VEGFR-2 ligands for treatment of breast cancer.

  2017cites this paper
• Synthesis, characterization, molecular docking and biological activity of 5,6-bis-(4-fluoro-phenyl)-3,4,7,8-tetraaza-bicyclo[8.3.1]tetradeca-1(13),4,6,10(14),11-pentaene-2,9-dione and its transition metal complexes

  2017cites this paper
• Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities.

  2017cites this paper
• Facile synthesis and antiproliferative activity of 7H-benzo[7,8]chromeno[2,3-d]pyrimidin-8-amines.

  2017cites this paper
• Recent developments of C-4 substituted coumarin derivatives as anticancer agents.

  2016cites this paper
• Pharmacophore modeling, 3D-QSAR, docking and ADME prediction of quinazoline based EGFR inhibitors

  2016cites this paper
• Coumarin as an Elite Sca ff old in Anti-Breast Cancer Drug Development: Design Strategies, Mechanistic Insights, and Structure–Activity Relationships

  year unknowncites this paper